StockData
Pasithea Therapeutics Corp. logo

Pasithea Therapeutics Corp. (KTTA) KPIs and segments

KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.43−0.07 (-13.14%)

Close on Nov 17, 2026Market cap $14.51MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Pasithea Therapeutics's business

Coming soon

This tab will track the numbers specific to Pasithea Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?